Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 13,558,000 | 13,172,000 | 12,872,000 | 12,120,000 | 11,776,000 |
| Cost of Goods | 3,324,000 | 3,234,000 | 3,173,000 | 3,096,000 | 3,022,000 |
| Gross Profit | 10,234,000 | 9,938,000 | 9,699,000 | 9,024,000 | 8,754,000 |
| Operating Expenses | 6,704,000 | 6,311,000 | 5,685,000 | 5,651,000 | 6,172,000 |
| Operating Income | 3,530,000 | 3,627,000 | 4,014,000 | 3,373,000 | 2,582,000 |
| Interest Expense | 275,000 | 264,000 | 246,000 | 221,000 | 217,000 |
| Other Income | 30,000 | 22,000 | 73,000 | -23,000 | 12,000 |
| Pre-tax Income | 3,285,000 | 3,385,000 | 3,841,000 | 3,129,000 | 2,377,000 |
| Income Tax | 465,000 | 200,000 | 595,000 | 441,000 | -261,000 |
| Net Income Continuous | 2,820,000 | 3,185,000 | 3,246,000 | 2,688,000 | 2,638,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 5,842,000 |
| Minority Interests | 2,000 | -4,000 | 0 | 0 | N/A |
| Net Income | $2,818,000 | $3,189,000 | $3,246,000 | $2,688,000 | $8,480,000 |
| EPS Basic Total Ops | 1.43 | 1.58 | 1.60 | 1.31 | 4.10 |
| EPS Basic Continuous Ops | 1.42 | 1.58 | 1.60 | 1.32 | 1.28 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 2.81 |
| EPS Diluted Total Ops | 1.40 | 1.57 | 1.59 | 1.31 | 4.06 |
| EPS Diluted Continuous Ops | 1.40 | 1.57 | 1.59 | 1.31 | 1.27 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 2.79 |
| EPS Diluted Before Non-Recurring Items | 1.98 | 2.06 | 1.97 | N/A | N/A |
| EBITDA(a) | $5,190,000 | $3,627,000 | $4,014,000 | $4,715,000 | $4,207,000 |